Home
KuDOS Pharmaceuticals

KuDOS Pharmaceuticals Market Share Analysis for July 2026

our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the uk is right at the heart of our efforts to do that.

Industry: N/A

Domainkudospharma.co.uk

Year Founded--

Employees51 - 200

Annual Revenue$10M - $15M

KuDOS Pharmaceuticals

KuDOS Pharmaceuticals (including company regionals)

kudospharma.co.uk

See more website traffic and engagement information

KuDOS Pharmaceuticals Revenue up to July 2026 is 10M - 15M

revenue generated by KuDOS Pharmaceuticals top domains

KuDOS Pharmaceuticals top domains revenue over 3 years

Revenue for KuDOS Pharmaceuticals top domains

kudospharma.co.uk10M - 15M

See more with Sales Intelligence

Total visits to KuDOS Pharmaceuticals's top domains

Understand KuDOS Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in KuDOS Pharmaceuticals's top domains

Analyze KuDOS Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on KuDOS Pharmaceuticals's top domains

See how KuDOS Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

KuDOS Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by KuDOS Pharmaceuticals

These are the website technologies, by industry, used by KuDOS Pharmaceuticals top domains

Mobile (2)

Meta Viewport

Conversion & Analytics (1)

Google Analytics

Marketing (1)

Google Marketing Platform

Payment & Currencies (1)

Pound Sterling

News & Signals from KuDOS Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAstraZeneca plc acquired Kudospharma for $210M on Jan 1st '05.He went on to found KuDOS Pharmaceuticals, which was acquired by AstraZeneca in 2005; Mission Therapeutics; and most recently Adrestia Therapeutics, which has operations in Cambridge, U.K. as well as in Cambridge, Massachusetts.

NewsKudospharma launches Learning Academy.AstraZeneca have unveiled a pioneering new Learning Academy at the Macclesfield Campus.

NewsKudospharma expands facilities to Macclesfield, United Kingdom, Northern Europe, Europe.Pharmaceuticals firm, AstraZeneca, has announced it is to invest £16.5 million into manufacturing facilities at its Macclesfield Campus.